Optomed Oyj

Share Issue/Capital Change • Dec 14, 2022

Disclosure 416044

Optomed Oyj - Total number of voting rights and capital

New shares subscribed for in Optomed Plc's directed share issue have been registered in the Finnish Trade Register

OPTOMED PLCSTOCK EXCHANGE RELEASE14 December 2022, at 9.00 EET New shares subscribed for in Optomed Plc's directed share issue have been registered in the Finnish Trade Register A total of 1,140,358 new shares subscribed for in Optomed Plc's directed share issue have been registered into the Finnish Trade Register today, on 14 December 2022. After the registration of the new shares, the company will have 16,541,355 shares in total of which 374,566 shares in treasury. The new shares produce the right to dividends and other distribution of assets as well as other shareholder rights as of this registration date. The new shares will be admitted to trading on the official list of Nasdaq Helsinki Ltd today. Optomed Plc Further enquiries Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com Distribution Nasdaq Helsinki Ltd Principal media www.optomed.com Optomed in Brief Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company's products are sold via various sales channels in over 60 countries globally.